AKAM Q1 2026 Earnings EPS Misses Estimates Stock Declines HOVNP Q1 2026 Earnings Preferred Stock Reports NarrowerthanExpected Loss on Strong Operating Trends Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development VUZI Q1 2026 Earnings EPS Beat and Narrowed Loss Boost Investor Sentiment PKX Q4 2025 Earnings Massive EPS Miss Highlights Severe Operational Headwinds KTB Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher